485 related articles for article (PubMed ID: 12648560)
1. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
2. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
[TBL] [Abstract][Full Text] [Related]
4. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Kreimann EL; Itoiz ME; Longhino J; Blaumann H; Calzetta O; Schwint AE
Cancer Res; 2001 Dec; 61(24):8638-42. PubMed ID: 11751376
[TBL] [Abstract][Full Text] [Related]
6. Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.
Heber EM; Kueffer PJ; Lee MW; Hawthorne MF; Garabalino MA; Molinari AJ; Nigg DW; Bauer W; Hughes AM; Pozzi EC; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2012 May; 51(2):195-204. PubMed ID: 22271404
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
[TBL] [Abstract][Full Text] [Related]
9. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
[TBL] [Abstract][Full Text] [Related]
10. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
[TBL] [Abstract][Full Text] [Related]
11. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa.
Morris GM; Coderre JA; Micca PL; Nawrocky MM; Hopewell JW; Miura M
Radiat Res; 2005 Jan; 163(1):72-8. PubMed ID: 15606309
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.
Garabalino MA; Heber EM; Monti Hughes A; González SJ; Molinari AJ; Pozzi EC; Nievas S; Itoiz ME; Aromando RF; Nigg DW; Bauer W; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2013 Aug; 52(3):351-61. PubMed ID: 23591915
[TBL] [Abstract][Full Text] [Related]
14. "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.
Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Quintana J; Santa Cruz GA; Trivillin VA; Schwint AE
Radiat Res; 2011 Apr; 175(4):463-72. PubMed ID: 21294607
[TBL] [Abstract][Full Text] [Related]
15. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.
Monti Hughes A; Longhino J; Boggio E; Medina VA; Martinel Lamas DJ; Garabalino MA; Heber EM; Pozzi ECC; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2017 Nov; 56(4):377-387. PubMed ID: 28871389
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
18. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model.
Heber EM; Hawthorne MF; Kueffer PJ; Garabalino MA; Thorp SI; Pozzi EC; Monti Hughes A; Maitz CA; Jalisatgi SS; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16077-81. PubMed ID: 25349432
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
